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CELIAC DISEASE  1 
ABSTRACT 
Celiac disease is a chronic autoimmune disease with physiological symptoms including 
diarrhea, vomiting, abdominal pain, and anemia. Weight change before and after 
treatment is common among women with Celiac disease. The relationship between the 
physical manifestations of Celiac disease and their effects on psychosocial functioning is 
unclear. The purpose of this study was to examine the effects of the magnitude of weight 
change on depression, body image, and eating behaviors. This cross-sectional study used 
data that were collected via online anonymous surveys from 140 women with Celiac 
disease. Functioning and adherence were assessed using the Patient Health 
Questionnaire-9 (PHQ-9), The Eating Attitudes Test (EAT), The Celiac Disease 
Adherence Test (CDAT), The Chronic Disease Self-Efficacy Scale (CDSES), and The 
Body Appreciation Scale 2 (BAS-2), and weight change was calculated from diagnosis to 
current weight (Body Mass Index, kg/m2).  Results showed no significant relationships as 
hypothesized between the magnitude of weight change and psychosocial variables 
(depression, eating behaviors, and body image; p > 0.05). Additionally, the relationship 
between self-efficacy and gluten-free diet adherence were not significant (p > 0.05).  
Relationships between length of time since diagnoses and self-efficacy, depression, body 
image, and eating behaviors were not found to be significant (p > 0.05). Participants, 
however, reported mean depression scores (M = 17.9, SD = 6.4) in the moderately severe 
range, suggesting that women with Celiac disease may benefit from screenings for 
depression and from the development of disease-specific interventions to address 
affective disorders in this population. 
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CHAPTER 1: INTRODUCTION 
Statement of the Problem 
Celiac disease is a chronic autoimmune disease affecting approximately 1% of the 
North American population (Gujral et al., 2012). Celiac disease is also globally prevalent, 
averaging between 0.5% and 1% in Asian, African, and European countries. The etiology 
of Celiac disease is both genetic and environmental (Gujral et al., 2012). Celiac disease is 
diagnosed using two screenings, a blood analysis and an additional confirmation through 
an intestinal biopsy (Gujral et al., 2012).  
Physiological symptoms of Celiac disease can include diarrhea, vomiting, 
abdominal pain, and anemia (Green et al., 2015). These symptoms are caused by 
inflammation in the small intestine, leading to symptoms similar to malnutrition and, 
therefore, making weight loss a common symptom of the disease. Many women 
experience significant weight loss prior to diagnosis (van Dommelen et al., 2008). 
Children with Celiac disease experience stunted growth; they are usually short in stature 
and have difficulty gaining weight (van Dommelen et al., 2008). Weight change also 
occurs when Celiac disease patients initiate treatment via a gluten-free diet. In some 
cases, patients may gain a significant amount of weight, leading to becoming overweight 
or obese (van Dommelen et al., 2008).  
The only proven treatment for Celiac disease is a gluten-free diet (Green et al., 
2015). A gluten-free diet is highly restrictive, as even trace amounts of gluten can cause 
damage or inflammation to the small intestine of a Celiac patient (Makovicky et al., 
2017). Although this diet alleviates most digestive symptoms, it may lead to increased 
sugar consumption, vitamin deficiencies, and weight gain (Bascunan et al., 2017). 
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However, some Celiac patients who adhere to a gluten-free diet gain nutritional benefits. 
These patients also tend to gain weight without increasing body mass index to the extent 
of becoming overweight or obese (Bascunan et al., 2017). The results of a gluten-free diet 
concerning weight change vary, as does the adherence of each individual patient and their 
subjective experience of Celiac treatment. Bandura’s self-efficacy theory provides a 
framework for increasing the likelihood that patients with Celiac disease will adhere to 
recommended behavioral changes. Self-efficacy is defined as the belief in the ability to 
make changes in order to obtain a specific outcome (Bandura, 1997). Applied to chronic 
illness, self-efficacy in one’s belief in their ability to adhere to treatment recommended 
by a medical professional to cure or manage symptoms of a disease (Greco et al., 2014). 
Increased self-efficacy also reduces one’s experience of depression and low mood 
(Bandura, 1997). The cyclical nature of the relationship between self-efficacy, treatment 
adherence, and depression shows the need for further research to bring clarity to this 
issue in Celiac disease, which requires behavioral changes to promote health. 
Although the exact relationship between Celiac disease and psychological 
symptoms is unclear, comorbidities exist between Celiac disease and several mental 
health conditions including depression, anxiety, and anorexia (Smith & Gerdes, 2012; 
Ricca et al., 2000). Cases of anorexia nervosa, though rarely studied, have been found in 
Celiac patients both prior to and after diagnosis of Celiac disease. Between 22% and 29% 
of individuals with Celiac disease score above clinical cut-off scores on anorexia and 
bulimia measures (Arigo et al., 2002; Karwautz et al., 2008). The relationship between 
anorexia and Celiac disease remains unclear. However, it is vital to recognize that there is 
a relationship between Celiac disease, its treatment, and disordered eating. Compared to a 
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healthy control group, adults with Celiac disease display higher rates of disordered 
eating—such as binging and restricting—as measured by the Eating Attitudes Test and 
Binge Eating Scale (Satherly et al., 2016). Mechanisms related to the development of 
disordered eating in patients with Celiac disease are not well understood, but may include 
body image disturbances given the potential for weight changes associated with 
adherence to a gluten-free diet. Therefore, it is vital to examine how body image in 
patients with Celiac disease is influenced by the implementation of a gluten-free diet.  
Depression is also documented in Celiac disease populations. Specifically, 37% of 
subjects in a study conducted by Arigo, Anskis, and Smyth (Arigo et al., 2012) met 
criteria for a diagnosis of depression, and all participants within that percentage reported 
greater perceived stress compared to those Celiac patients who did not meet criteria for a 
mental health diagnosis. It is possible that depression in Celiac disease patients is 
increased by diet and perceived food-related stress (Arigo, Anskis, &Smyth, 2012). Strict 
adherence to the recommended gluten-free diet can be stressful for some patients. Many 
consider the diet burdensome and express negative attitudes about living with this 
condition despite improvements in their physical symptoms after incorporating the 
recommended dietary changes (Whitaker et al., 2009).  
Body image is defined as “a cognitive representation of physical appearance” 
(Wolzon, 1998). Body image may not always be an accurate representation of actual 
appearance (Glashouwer et al., 2018). Whether or not body image reflects actual 
appearance, negative body image may influence behavior through resulting negative 
cognitions, disordered eating behaviors, or poor adherence to diet restrictions or medical 
treatment (Wolzon, 1998). Patients living with chronic illness are more likely to report 
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poorer body image than healthy peers (Pinquart 2013), which may relate to loss of bodily 
functions, weight change, or abnormal physical features associated with the chronic 
illness. Patients with Celiac disease experiencing weight and diet changes are more likely 
to have a negative body image.  
Although some research has been conducted on the subjective experiences of 
those with Celiac disease, literature concerning psychological interventions is lacking. 
Existing research shows that those with Celiac disease often experience depressive 
symptoms, abnormal eating habits, and negative body image, but does not clarify the 
relationships between these factors or their relationship to dietary adherence (Arigo et al., 
2012). This lack of clarity has contributed to the absence of evidence-based 
psychological screenings and interventions to increase treatment adherence and improve 
mental and physical health in patients with Celiac disease (Pinquart 2013).  
Purpose of the Study 
While many studies examine the overall quality of life for patients with Celiac 
disease, few studies have evaluated weight, disordered eating, and body image in this 
population. The purpose of this study was to examine how physical and behavioral 
factors following the implementation of a gluten-free diet influence psychosocial 
functioning and adherence in adult women with Celiac disease. Examining the 
relationship between these variables may help to identify appropriate strategies to 
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Hypotheses 
Hypothesis 1 
a. It was hypothesized that the magnitude of weight change would predict 
psychosocial functioning, as defined by level of depressive symptoms, 
maladaptive eating behaviors, and body image in women living with Celiac 
disease (as measured by the Eating Attitudes Test [EAT], Body Appreciation 
Scale [BAS-2], and Patient Health Questionnaire-9 [PHQ-9]. 
b. It was hypothesized that greater magnitude of weight change would 
significantly relate to higher rates of depressive symptoms, greater endorsement 
of maladaptive eating behaviors, and poorer body image. 
Hypothesis 2 
It was hypothesized that higher levels of self-efficacy (as measured by the 
Chronic Disease Self Efficacy Scale) would correlate with better dietary adherence (as 
measured by the Celiac Disease Adherence Test [CDAT]). 
Hypothesis 3 
It was hypothesized that women more recently diagnosed with Celiac disease, less 
than one year, would report lower self-efficacy and higher psychosocial dysfunction, as 
defined by depressive symptoms, maladaptive eating behaviors, and poorer body image, 
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CHAPTER 2: REVIEW OF THE LITERATURE 
Celiac Disease 
Celiac disease is an auto-immune disorder that causes chronic inflammation in the 
intestines upon exposure to gluten. Gluten is a set of proteins found in cereal grains, 
barely, wheat, and rye (Salazar et al., 2017). Exclusion of gluten from the diet heals this 
inflammation and stops further damage to the bowels (Shannahan & Leffler, 2017). 
Celiac disease affects approximately three million Americans. Approximately 60% to 
70% of those diagnosed with Celiac disease are women, with the average age of 
diagnosis falling between 40 and 60 years of age (“Beyond Celiac”, n.d.). However, the 
overall prevalence of this condition is similar across age groups—0.8% for children, 
adolescents, adults, and the elderly (Salazar et al., 2017).  
The etiology of Celiac disease is both genetic and environmental. The disease is 
passed through HLA (human leukocyte antigen) and non-HLA genes and is triggered by 
environmental exposure to gluten (Gujral et al., 2012). One study examining the 
prevalence of Celiac symptoms among first-degree relatives of diagnosed Celiac patients 
showed that 16.9% of first-degree relatives tested positive for Celiac disease using a 
blood analysis (Araya et al., 2015). Each first-degree relative and Celiac patient was 
questioned regarding symptomatic experience. More women endorsed classic 
symptomology including diarrhea, weight loss, and abdominal pain.  
Celiac disease is diagnosed using two screenings, beginning with blood analysis. 
If bloodwork analysis is positive for anti-tissue transglutaminase antibodies, then an 
intestinal biopsy is conducted to confirm the diagnosis. Both procedures must be 
conducted while the patient is following a gluten-containing diet to avoid false negative 
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results (Shannahan & Leffler, 2017). Diagnosis can be difficult, as accurate results cannot 
always be obtained by blood analysis or intestinal biopsies. Patients with co-morbid 
immunoglobulin A (IgA) deficiency usually do not test positive for tissue 
transglutaminase antibodies, a common marker for Celiac disease in the blood (Salazar et 
al., 2017). This is just one example of complications that can occur with diagnostic 
procedures, especially with blood analysis. Therefore, intestinal biopsy is considered the 
gold standard for Celiac disease diagnosis (Green et al, 2001).  
 Symptoms of Celiac disease vary greatly among individuals. Gastrointestinal 
symptoms include diarrhea, vomiting, abdominal pain, and bloating. Diarrhea, weight 
loss, and fatigue are referred to as classical symptoms.  Non-classical symptoms include 
confusion, anemia, bone density loss, thinning hair, and joint pain (Newnham et al., 
2016). In addition, Celiac disease is associated with an increased risk of intestinal 
malignancy over the lifespan (Green et al. 2001). Malabsorption of nutrients that occurs 
in celiac disease leads to a lack of vitamins essential for immune function, bone growth, 
hair growth, and reproductive functioning in women which can contribute to infertility, 
miscarriage, premature birth, or stillbirth (Shannahan & Leffler, 2017).  
 There are several common comorbidities of Celiac disease that span both 
physiological and psychological domains. Celiac disease is commonly comorbid with 
other autoimmune disorders such as type 1 diabetes, Hashimoto’s disease, and other 
thyroid diseases (Collin & Maki, 1994; Green et al., 2001). Associations have also been 
shown between Celiac disease and psychological disorders. Comorbidities include eating 
disorders and depression (Arigo et al., 2012). Managing symptoms of Celiac disease 
requires constant food monitoring and restriction. This can lead to unhealthy eating 
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behaviors or negative attitudes toward food. In some cases, Celiac patients develop 
comorbid eating disorders, meeting criteria for anorexia or bulimia. The prevalence of 
eating disorders among Celiac diagnosed adolescents (16%) is much higher than that of 
the general population (1%) (Karwautz et al., 2008). Depression is also commonly 
experienced by patients with Celiac disease. Those with increased perceived stress and 
more severe symptoms of the disease are more likely to report clinical levels of 
depression (Arigo et al., 2012). Therefore, psychological screening is recommended even 
when dietary adherence is high and physical symptoms are controlled.  
 A gluten-free diet is currently the only treatment for Celiac disease. Implementing 
a gluten-free diet over a lifetime, however, may be challenging for some patients. Cross-
sectional studies have suggested that nearly 50% of patients following a gluten-free diet 
continue to ingest gluten, both intentionally and unintentionally (Silvester et al., 2016). 
Unintentional gluten ingestion occurs most commonly with cross contamination from 
kitchen or factory equipment. A study examining reasons for gluten ingestion found that 
over 60% of participants ingested a food that they did not know had a gluten ingredient, 
whereas 29% were in a restaurant without gluten-free options (Silvester et al., 2016). 
Additionally, 7% reported frustration with the gluten free diet and ate gluten-containing 
foods out of spite, while 6% did not want to offend their host by not eating what they 
were offered. As a result, 80% of participants who ingested gluten reported experiencing 
abdominal pain and 54% reported experiencing diarrhea (Silvester et al., 2016).  
 While a gluten-free diet alleviates symptoms and intestinal inflammation, this diet 
can create residual complications. Gluten-free foods often use rice as a replacement for 
wheat and other grains derived from gluten and may not provide adequate vitamins and 
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nutrients. Patients following a gluten-free diet, especially women, typically have a lower 
intake of vitamin D, magnesium, iron, zinc, and fiber. Therefore, Celiac patients may 
need to supplement their diet (Bascunan et al., 2017). In addition, gluten-free diet 
followers take in increased amounts of simple carbohydrates, as compared to those who 
include gluten in their diet, and are lacking in complex carbohydrates. The complexity of 
diet and nutritional maintenance can lead to unplanned weight change or other health 
problems (Wilde et al., 2010).   
Celiac Disease and Weight Change 
 Celiac patients’ experiences concerning weight change vary both before and after 
diagnosis. Weight loss is a typical symptom of Celiac disease, although not all Celiac 
patients are underweight at diagnosis. A study conducted on adolescent Celiac patients 
found that 27.2% of participants were underweight at diagnosis, while 63.6% were 
normal weight and 9% were overweight or or obese (Dehghani et al., 2017). Normal or 
overweight BMI for undiagnosed Celiac patients is most commonly due to comorbidities 
such as diabetes, thyroid disorders, or cardiovascular disease (Kabbani et al., 2012).  
 While the effects of a gluten-free diet on BMI and nutritional health vary 
individually, some studies show evidence of increased BMI and increased waist 
circumference. Out of 185 participants, approximately 23% experienced waist 
circumference increases after implementing a gluten-free diet. Approximately 42% had a 
BMI greater than 25 kg/m2, as compared to 24.3% at diagnosis of Celiac disease 
(Ciccone et al., 2018). Another study conducted with 98 adult Celiac patients found that 
29.5% of participants met diagnostic criteria for metabolic syndrome after following a 
gluten-free diet for one year (Tortora et al., 2015). Foods that are not naturally gluten-free 
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tend to have a high glycemic index which may contribute to cases of metabolic syndrome 
and increased BMI (Ciccone et al., 2018). Another study found that 22.3% of participants 
gained more than two BMI points after beginning a gluten-free diet after Celiac 
diagnosis. Of that percentage, 17% moved from the normal weight category to the obese 
category (Kabbani et al., 2012).  
Depression 
Many patients seeking medical treatment for gastrointestinal related illnesses 
report symptoms of affective psychological disorders; specifically, 27% report symptoms 
of depression (Addolorato et al., 2008). Depressive symptoms may relate to 
malabsorption due to Celiac disease, higher levels of inflammation, poor adaptation to 
diet change, or a combination of these factors (Addolorato et al., 2004). Depressive 
symptoms in patients with Celiac are associated with perceived difficulty of dietary 
adherence. Motivation to adhere to a gluten free diet consists primarily of physical 
factors—pain, gastrointestinal symptoms, and long-term health risks. Experiencing pain 
and chronic illness alone contributes to depressed mood. Conversely, emotional stressors 
may serve as possible deterrents to adherence—seeing others eat preferred foods that 
contain gluten, eating at work or in a restaurant, irritability or mood change from 
ingesting gluten, or viewing resulting symptoms as a punishment for eating gluten 
(Houbre et al., 2017). 
 Celiac patients who receive psychological support have increased dietary 
adherence. Celiac patients are more likely to intentionally ingest gluten when stressed. 
Patients who do not believe they are supported by medical professionals or peers are 
more likely to perceive a gluten free diet as distressing and are less motivated to follow 
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through with treatment (Sainsbury et al., 2018). This is most likely to occur immediately 
after diagnosis. Celiac patients are recommended to immediately begin a gluten-free diet, 
which entails reading labels on every food item, eliminating preferred foods that contain 
gluten, and dining out only when a restaurant can accommodate gluten restrictions. For a 
patient learning this information for the first time, this can be emotionally distressing 
(Stone et al., 2012).  
Eating Behaviors and Body Image 
Female Celiac patients, especially adolescents, show higher rates of unhealthy 
eating behaviors. Female patients have been shown to engage in restricting food, binge 
eating, or “gluten purging”, which involves purposefully eating gluten containing foods 
to induce diarrhea or vomiting. While these behaviors are often subclinical, the patient 
can still be at increased risk for developing an eating disorder (Karwautz et al., 2012). 
Patients who engage in these behaviors report doing so due to concerns about body shape 
and weight, rather than out of concern for gluten-free diet adherence. Further, patients 
who reported eating pathology were less likely to adhere to the gluten-free diet. Whether 
a pre-existing eating pathology is influencing treatment adherence or treatment adherence 
is increasing eating pathology, it is vital that Celiac patients be monitored for unhealthy 
eating behaviors or eating disorders.  
 Body image has been used to describe both behavioral and cognitive aspects of 
one’s feelings concerning their appearance. Behavioral manifestations of negative body 
image include disordered eating behaviors such as binge eating or restricting. Cognitive 
manifestations include depressed affect, emotional distress, and preoccupation with 
weight or appearance (Altabe & Thompson, 1996). Body image becomes poorer when 
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one’s view of their own body, known as their actual body image, is different than their 
ideal body image—the image they believe they should look like. The higher the 
discrepancy one perceives between these two concepts, the more negative their body 
image is likely to be (Glashouwer et al., 2018).  
 Concerns about shape, weight, and appearance are shown to be higher among the 
Celiac patients compared to the normal population (Arigo et al., 2012). Women with 
Celiac disease have reported higher incidents of restricting food intake and binge eating 
in correlation with concerns about shape and weight rather than symptom severity or 
bodily functions (Arigo et al., 2012). This suggests that body image plays a large role in 
treatment adherence and psychological functioning. Whether the origins of negative body 
image stem from cultural norms or personal cognitive schema, this crucial concept has 
influence over one’s behavior. For those with chronic illnesses like Celiac disease, poor 
body image is a factor than determine one’s adherence to treatment and, therefore, one’s 
physical health. 
This reflects literature examining the relationship between body image and 
chronic illness. Those with chronic illness are more likely to have a poorer body image 
than their healthy peers (Pinquart, 2013). There are several factors that account for a 
poorer body image in those with chronic illness. Body image is more likely to be 
negatively impacted by a diagnosis of chronic illness if the patient is female and is older 
at the time of diagnosis. Those diagnosed with a chronic illness in childhood build coping 
skills early in life and do not have extended experiences of pre-diagnostic life to compare 
their current experience to (Pinquart, 2013). In addition to sex and age, there are specific 
aspects of chronic illness that increase the likelihood of poor body image. Chronic 
CELIAC DISEASE  14 
illnesses that have symptoms involving weight change, physical deformity, or loss of 
bodily functions result in patients feeling as if they appear sickly to others, impacting 
body image (Pinquart, 2013).   
Self-Efficacy 
 Self-efficacy is defined as the ability to use psychological flexibility and self-
control in order to reach a specified goal (Bandura, 1997). The concept of self-efficacy 
has been used to help therapy clients diagnosed with depression and other affective 
disorders with motivation and goal setting. The more an individual believes that their 
goals can be achieved, the more effort they will expend. Also, they will handle failures or 
setbacks better than those with lower self-efficacy. Those with higher self-efficacy are 
more willing to engage in difficult tasks with optimism, whereas those with lower self-
efficacy avoid tasks or situations which they perceive to be difficult. This can cause a 
cyclical effect; those with higher self-efficacy attract support with their optimism and 
small successes, while those with low self-efficacy may push away others who offer help 
and escalate their depression affect and avoidance with multiple small failures (Bandura, 
1997).  
 Self-efficacy is vital not only for mental health goals, but also for health-related 
behavior change. The role of self-efficacy has been studied with behavior change in 
patients with obesity, chronic obstructive pulmonary disease (COPD), and other diseases 
(Bonsaksen et al., 2014). Self-efficacy can diminish as a result of personal circumstances 
such as low financial resources, few social supports, and amount of time living with the 
medical diagnosis. When someone with low self-efficacy is faced with a chronic illness 
requiring behavior change, their disbelief in their ability to successfully make changes 
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can lead to depression and low adherence to medical treatment (Greco et al., 2014). A 
study conducted with cardiac patients showed that those with higher self-efficacy spent 
more time completing rehabilitation requirements (Steca et al., 2013). In addition, those 
with less negative perceptions about their symptoms during onset of an illness responded 
more quickly to treatment (Steca, et al. 2013).  
 According to Bandura (1997), there are four components, or ways to build, self-
efficacy. The first is to have the experience of success over a stressing obstacle. If the 
obstacle is easy, the person is more likely to avoid obstacles that are difficult or 
distressing. Once an individual experiences mastery over an obstacle, challenges become 
less distressing. Second, one must be exposed to social modeling. Seeing others succeed 
can be motivating, while seeing others in similar situations fail causes one to feel 
negatively about their own possibility of success. Social persuasion occurs when a person 
acts as a support to the patient, emphasizing success and a positive outlook rather than 
failures or negative experiences. The final component is learning to interpret one’s own 
affect and physical sensations. Those with low self-efficacy tend to misread anxiety and 
depression as personal weakness and associate physical fatigue and pain as failure. 
Patients with chronic illness can apply these concepts to support plans to increase life 
satisfaction and positive responses to treatment as well as adherence to medical 
treatment.   
Celiac disease, with its varied presentation and onset, has symptoms including 
physical discomfort and psychological difficulty. Depression, binge eating or restricting 
food intake, and poor body image may complicate treatment of Celiac disease. 
Examining the role of self-efficacy within the context of Celiac disease and clarifying the 
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relationship between these variables and dietary adherence can help medical and mental 
health professionals improve dietary adherence for patients with Celiac disease.  
 Interventions recommended by physicians for patients with Celiac include 
intensive consultation with a dietician, access to an advocacy group, and long term 
follow-up with primary care, a nutritionist, and gastroenterologist when necessary. It is 
recommended that the consulting dietician be expertly trained to work with Celiac 
patients as to provide accurate patient education on the disease (Niewinski, 2008). 
Support groups and long-term dietary counseling are especially encouraged when the 
patient does not adhere to a gluten-free diet. Physicians may recommend that patients use 
websites and online support groups to increase compliance and knowledge about the 
disease (Young & Thomas, 2004). This can be problematic since information on websites 
concerning Celiac may be medically inaccurate or incomplete. An analysis of 98 websites 
found that 48% of the websites provided information about Celiac disease that was less 
than 95% accurate—meaning that the information provided was not consistent with 
information provided by medical professionals—while 52% of the websites contained 
less than 50% of information about the disease considered to be core information for 
inclusion (McNally et al., 2012). While patients who report comorbid depression or 
anxiety are commonly treated with selective serotonin reuptake inhibitors (SSRIs) 
literature on psychological interventions is sparse (Arigo et al., 2012). No psychological 
interventions have specifically addressed psychosocial functioning or dietary adherence 
in patients with Celiac disease.  
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CHAPTER 3: METHOD 
This study examined how implementation of a gluten free diet influences 
depression, eating behaviors, and body image in adult women with Celiac disease within 
the context of the self-efficacy model (Bandura, 1997). This study used a quantitative, 
cross-sectional, and correlational design. Data were collected via survey and were 
anonymous (no protected health information was collected). Multiple regression models 
determined the relationship between independent variables (weight change, self-efficacy, 
and time of diagnosis) and psychological functioning (depressive symptoms, maladaptive 
eating behaviors, and body image) in women who live with Celiac disease.  
Participants 
It was estimated that 120 participants would be required to achieve adequate 
power for regression analyses (minimum 107 completed surveys; Tabachnick & Fidell, 
2007). In total, 123 participants were recruited for this study.  
Inclusion and Exclusion Criteria 
To be eligible for this study, participants had to be 18 years of age or older, 
female, and have a self-reported diagnosis of Celiac disease via blood analysis or an 
intestinal biopsy.  Potential participants who followed a gluten-free diet before Celiac 
disease diagnosis, were unable to provide consent to participate, or were not English 
speaking were not eligible to participate in this study. 
Screening and Recruitment 
Participants were recruited through study advertisement posts on social media 
platforms Facebook and Twitter as well as ResearchMatch. ResearchMatch is a database 
of individuals interested in participating in health-related research. A request was 
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submitted through ResearchMatch inviting participants based upon inclusion criteria. The 
link for the study was then sent to interested participants via email through 
ResearchMatch. Posts on social media websites were used to gather participants, inviting 
them to respond to the post to participate in the study. In appreciation for participation, 
participants were offered the opportunity to enter in a raffle for a $25 gift card for 
Amazon at the end of the survey.  
Measures 
Screening 
  Potential participants were asked to answer screening questions online following 
the study description (age 18 or older, biological sex female, Celiac diagnosis, gluten free 
diet initiation timing) and before survey questions began. They were also asked to check 
a box acknowledging that they voluntarily agreed to participate in this study. 
Demographic Questionnaire  
Participants were asked to complete a questionnaire to collect demographic 
information. Participants provided their age, method and time of diagnosis of Celiac 
disease, height, and weight. 
Depression  
The Patient Health Questionnaire-9 (PHQ-9; Kroenke, et al. 2001) is a 9 item 
self-report measure designed to assess for depressive symptoms in adults based upon 
DSM-5 criteria. This measure includes items that are designed to assess for behavioral, 
affective, and cognitive symptoms of depression including depressed mood, suicidality, 
loss of interest or pleasure in preferred activities, and changes in sleep patterns or 
appetite. Each item is measured using a 4-point scale of 0-3, with 3 indicating the highest 
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severity. Scores of 0-4 are indicative of no clinical level of depression. Scores of 5-9 are 
indicative of clinically mild levels of depression. Scores of 10-14 are indicative of 
clinically moderate levels of depression. Scores of 15-19 are indicative of moderately 
severe levels of depression. Scores of 20-27 are indicative of clinically severe levels of 
depression. The PHQ-9 has been shown to be valid in adult population samples and 
reliable in medical settings (Kroenke et al., 2001). The PHQ-9 has been shown to be 
positively correlated with the Beck Depression Inventory-II (BDI-II; Ghazisaeedi et al., 
2021). The PHQ-9 has shown high internal consistency (α = 0.80; Cassiani-Miranda, et 
al., 2021). 
Eating Behaviors and Attitudes.  
The Eating Attitudes Test (EAT; Garner et al., 1982) is a 26 item, self-report 
questionnaire designed to measure disordered eating behavior in the general population 
and to screen for those individuals who may be more likely to meet criteria for or develop 
an eating disorder (Richter et al., 2016). Item responses are Likert-style, allowing the 
participant to choose between “always”, “usually”, “often”, “sometimes”, “rarely”, and 
“never”. Items cover eating behaviors, cognitions, and emotions concerning food. The 
EAT-26 correlates highly with the original 40 item scale (r = .98; Garner & Garfinkel, 
1979; Garner et al., 1982). The original EAT-40 shows high internal reliability (α = 0.94). 
This measure has also shown high concurrent validity, as EAT scores were highly 
correlated with criterion group membership (r = 0.87, P < 0.001). 
Gluten-Free Diet Adherence  
The Celiac Disease Adherence Test (CDAT; Leffler et al., 2008) is a 
standardized. 7-item questionnaire used to measure adherence to a gluten-free diet in 
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Celiac patients. This measure is comparable to blood analysis, performing significantly 
better than immunoglobulin A tissue transglutaminase testing with a sample of 200 
biopsy-proven Celiac patients (P = .001; Leffler et al., 2008). Questions are answered 
using a 1 to 5-point Likert scale. Possible scores range from 7 to 35, with higher scores 
being indicative of poor adherence. This measure is highly correlated with the 
standardized dietician evaluation (SDE) for gluten exposure (P < .01) and has a high test-
retest reliability with a Pearson correlation coefficient of 0.823.  
Self-Efficacy  
The Chronic Disease Self-Efficacy Scale (CDSES; Lorig et al., 1996) is a 33-
item, self-report measure designed to assess the impact of chronic illness on one’s 
perceived ability to carry out normal functioning in several domains (Lorig et al., 1996). 
Items address the following areas of functioning: exercise, acquiring information about 
the disease, support system, communication with a physician, disease management, 
chores, engagement in social activities, symptoms management, and depression 
management. A scale of 1 to 10 is used for each item, 1 “not confident at all” and 10 
“totally confident”. A higher score indicates higher self-efficacy. This measure was used 
on adult subjects of varied age range with different diagnoses—diabetes, arthritis, and 
hypertension (Kim et al., 2012). This measure has been shown to have internal 
consistency with an overall alpha coefficient of 0.96 (Lorig et al., 1996).  
Body Image  
The Body Appreciation Scale 2 (BAS-2; Tylka & Wood-Barcalow, 2015) was 
used to measure body image. This 10-item, self-report questionnaire measures the level 
of comfortability with one’s body and positive cognitions related to body image. Each 
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item is rated using a 5-point Likert scale, with 1 meaning “never” and 5 meaning 
“always”. Higher scores are indicative of a more positive body image. The internal 
consistency reliability was high for women (Cronbach’s alpha = 0.94). Item total 
correlations ranged between 0.62-0.88 for women.  
Body Mass Index  
A standardized calculation is used to measure body mass index (BMI, kg/m2). 
Weight for adjusted height is calculated using weight/height2 to find total body fat mass 
(Cole, 1979). A BMI of less than 18.5 is considered underweight. A BMI between 18.5 
and 24.9 is normal weight. A BMI of 25 to 29.9 is overweight. A BMI above 30 is in the 
obese range. Participants were asked to estimate their height as well as their weight, pre 
and post diagnosis, for the researcher to calculate BMI. 
Procedures 
Participants were recruited from Facebook, Twitter, and ResearchMatch. They 
were given a brief description of the study and a link to the survey. All study procedures 
were approved by the Philadelphia College of Osteopathic Medicine Institutional Review 
Board.  
Potential participants who clicked on the study link were asked to answer brief, 
open ended questions concerning their diagnosis, including the date of and method of 
diagnosis of Celiac disease, to ensure inclusion criteria were met. These questions served 
as a screening tool at the beginning of the survey. Potential participants were then read an 
informed consent page outlining the study details and the voluntary nature of 
participation. Potential participants who agreed to participate clicked a button to opt-in 
and begin the online survey. 
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The survey was estimated to be about 30 minutes in length. This survey was 
anonymous and did not collect any protected health information. This survey was 
delivered and collected electronically using REDCap. Study data were collected and 
managed using REDCap electronic data capture tools hosted at the Philadelphia College 
of Osteopathic Medicine. REDCap (Research Electronic Data Capture) is a secure, web-
based software platform designed to support data capture for research studies, providing 
(a) an intuitive interface for validated data capture, (b) audit trails for tracking data 
manipulation and export procedures, (c) automated export procedures for seamless data 
downloads to common statistical packages, and (d) procedures for data integration and 
interoperability with external sources (Harris et al., 2009; Harris et al., 2019). 
Participants who do not meet the inclusion criteria were diverted to another screen 
thanking them for their participation. Participants who completed the survey were 
provided a separate link at the end of the survey to enter their contact information for an 
optional raffle. Data were transferred to SPSS and analyzed. 
Statistical Analysis 
Descriptive statistics were used to characterize the sample (means, standard 
deviations, and frequencies). Data were evaluated for outliers using minimum and 
maximum values and scatterplots. Correlations and t tests were used to evaluate the 
relationship between demographic variables and dependent variables. Demographic 
variables significantly associated with dependent variables were included in regression 
models. Linear regressions were used to analyze the relationships between independent 
and dependent variables for hypotheses one through three. The Enter Method was used 
for the regression method.  
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Assumptions of regression were tested prior to building regression models. 
Pearson correlations were run between all variables to determine multicollinearity. The 
cutoff for independent variable correlations was 0.7. The variance inflation factor was 
also evaluated. The second assumption for linear regression is a normal distribution of 
data. Normality was evaluated using the Shapiro-Wilk test and visualized the data with 
histograms. Finally, data were evaluated for homoscedasticity using scatter plots.  
It was hypothesized that the magnitude of weight change would predict 
psychosocial functioning, as defined by levels of depression, eating behaviors, and body 
image in women living with Celiac disease (as measured by the EAT-26, BAS-2, and 
PHQ-9).  It was hypothesized that greater magnitude of weight change would be related 
to higher rates of depression, pathological eating behaviors, and poor body image. For the 
first step of the model, significant demographic variables were entered. The independent 
variable (weight change) was then entered into three different regression models with the 
outcomes for the dependent variables of EAT-26, BAS-2, and PHQ-9.  
The independent variable (self-efficacy, as measured by the CDSES) was entered 
into a regression model with the outcome for the dependent variable of dietary adherence 
(CDAT). The independent variable of the time of diagnosis was entered into a regression 
model with the outcome for the dependent variables of self-efficacy, depression, eating 
behaviors, and body image. A sample size of 107 was needed based on power and sample 
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CHAPTER 4: RESULTS 
Participants 
In total, 140 individuals expressed interest in this study. Of the 140, 123 adult 
female participants met inclusion criteria and were recruited for this study. Of the 123 
participants, 119 (96.7%) completed at least demographic data and were included in 
analyses. The mean age of participants was 39.7 years (SD = 13.8). Additionally, 37.4% 
of participants reported following a gluten-free diet for less than one year, 4.1% for 1-2 
years, 33.3% for 2-10 years, and 22% for 10 years or more. Two participants reported 
that they were pregnant at the time of the study and were not included in analyses. 
Sample characteristics are in Table 1.   
Of the 119 participants that completed demographic questions, 37.4% reported 
that less than one year since time of diagnosis, 4.9% reported 1-2 years, 34.1% reported 
2-10 years, and 22.8% reported 10 years or more. It is possible that individuals were 
diagnosed with Celiac disease in childhood; therefore, a larger variance of weight at the 
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Table 1 
Characteristics of Survey Respondents  
Variable Frequency  Percent M (SD) 
    
Age (years) 119  39.7(13.8) 
Current Weight (pounds) 
Diagnostic Weight (pounds) 






     <1  35  
     1-2  4.9  
     2-10  34.1  
     10+  22.8  
Time on gluten-free diet (years) 119   
     <1  37.4  
 
     1-2  4.1  
     2-10  33.3  
     10+  22  
    
 
In total, 108 participants provided their current weight and height information. 
However, after removing one outlier, weight data were available for 107 participants. The 
mean weight and Body Mass Index (kg/m2), as well as weight categories of participants 
(overweight/obese or healthy) are included in Table 2.  
Table 2 
Descriptive Data for Body Mass Index of Participants  
Variable N  Minimum Maximum M (SD) Percent 
      
BMI (kg/m2) 119 15.8 52.7 26.7(7.7)  
BMI Category      
       Healthy 48    38.7 
       Overweight 35    32.3 
       Obese  34    27.4 
       Underweight 2    1.6 
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Depressive Symptoms 
In total, 114 participants completed the PHQ-9 and reported a mean score of 17.9 
(SD = 6.4), representing a “moderately severe” level of depression. Visual depictions of 
the data and a Kolmogorov–Smirnov (K-S) test suggested that depression scores were not 
normally distributed (p < 0.001). Given that these data were not normally distributed, 
logarithmic transformations with base 10 (log(10)) transformations were attempted. 
Despite these transformations, data remained deviant from a normal distribution (p = 
0.035). Therefore, non-transformed data were used in analyses and non-parametric tests 
were used to confirm any significant findings when possible. Descriptive data for the 
PHQ-9 are in Table 3. 
Table 3 
Descriptive Data for Depression, Body Image, Diet Adherence, Self-Efficacy, and Eating 
Behaviors in Women with Celiac Disease 
Variable  N Min* Max** Mean(SD) K-S  
PHQ-9 114 9 36 17.9 (6.4) 0.1  
BAS-2 114 1.1 5 3.2 (0.8)  0.2***  
CDAT 112 8 35 21.9 (7.1) 0.1  
CDSES 103 1.82 9.91 6.58 (2) 0.1  
EAT-26 101 0 61 11.8 (10.4) 0.1  
*Minimum 
**Maximum 
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Body appreciation 
In total, 114 participants completed the body appreciation scale and reported a 
mean score of 3.23 (SD = 0.884; Table 2). K-S tests and visual plots of BAS-2 scores 
indicated that data were normally distributed (p = 0.200). Descriptive data for the BAS-2 
scores are in Table 3. 
Dietary Adherence 
Overall, 112 participants completed the CDAT and reported a mean score of 21.9 
(SD = 7.01; Table 2).  A K-S test and visual depiction of the data suggested that CDAT 
total scores were not normally distributed (p < 0.001). Given that these data were not 
normally distributed, log (10) transformations were attempted. Despite these 
transformations, data remained deviant from a normal distribution (p < 0.001). Therefore, 
non-transformed data were used in analyses and non-parametric tests were used to 
confirm any significant findings, as appropriate. Descriptive data for the CDAT scores 
are in Table 3. 
Self-Efficacy 
Overall, 103 participants completed the CDSES and had a mean score of 6.58 (SD 
= 2.06). The data were not normally distributed (p < 0.001). Given that these data were 
not normally distributed, logarithmic transformations were attempted. Despite these 
transformations, data remained deviant from a normal distribution (p < 0.001). Therefore, 
non-transformed data were used in analyses and non-parametric tests were used to 
confirm any significant findings, as appropriate. Descriptive data for the CDSES scores 
are in Table 3. 
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Eating Attitudes 
In total, 101 participants completed the EAT-26 and had a mean score of 11.89 
(SD = 10.4). A K-S test and visual depiction of these data indicated that EAT-2 scores 
were not normally distributed (p < 0.001). Given that these data were not normally 
distributed, log (10) transformations were attempted. The log transformations resulted in 
EAT-26 scores representing a normal distribution (K-S = 0.72, p = 0.20). Therefore, 
transformed data were used in analyses for relevant hypotheses. Descriptive data (non-
transformed) for the EAT-2 scores are in Table 2. 
Additionally, 17 participants scored a minimum of 20 or higher on the EAT-2, 
indicating that they met or exceeded the screening cutoff used for this measure to indicate 
the potential for an eating disorder.  
Prior to conducting analyses to address the hypotheses, preliminary analyses were 
conducted to determine any significant relationships between patient demographic 
characteristics and the study measures (CDAT, CDES, PHQ9, BAS-2, EAT-26). 
Significant relationships found between demographic variables and outcomes were 
subsequently included in relevant regression analyses. Specifically, participants’ self-
reported current weight significantly correlated with depression scores (r = 0.24, p = 
0.013), body appreciation (r = -0.41, p < 0.001), Celiac disease adherence (r = 0.219, p = 
0.026), self-efficacy (r = -0.321, p = 0.001), and eating behaviors (r = 0.262, p = 0.011). 
Categorical variables, including time following a gluten-free diet, were dummy coded 
prior to use in regression analyses. A correlation matrix is in Table 4. 
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Table 4 
Correlations between Demographic and Patient Characteristics and Study Outcomes 
Measures 
Variable  Diet Time Age  Current 
Weight 
PHQ-9 Total 
Diet Time  Pearson Correlation 1   0.200*  
 Sig. (2-tailed)    0.033  
 N 
 
133   114  
Age  Pearson Correlation  1 0.076 -0.174  
 Sig. (2-tailed)   0.431 0.064  
 N 
 
 119 110 114  
Current 
Weight 
Pearson Correlation   0.076 1 0.242* 
0.013 
 
 Sig. (2-tailed)  0.431    
 N 
 
 110 110 105  
       
PHQ-9 Total Pearson Correlation  -0.174 0.242* 1  
 Sig. (2-tailed)  0.064 0.013   
 N  114 105 114  
BAS-2 Total Pearson Correlation   0.078 -0.410** -0.619** 
 Sig. (2-tailed)  0.407 0.000 0.000 
 N 
 
 114 105 114 
CDAT Total Pearson Correlation  -0.088 0.219* 0.348** 
 Sig. (2-tailed)  0.356 0.026 0.000 
 N  112 103 112 
CDSES Total Pearson Correlation  0.176 -0.321** 0.682** 
 Sig. (2-tailed)  0.075 0.001 0.000 
 N  103 95 0.103 
EAT-26 Total Pearson Correlation  -0.068 0.262* 0.353** 
 Sig. (2-tailed)  0.501 0.011 0.000 
 N  100 93 100 
Variable  BAS-2 
Total 
CDAT Total CDSES 
Total 
EAT-26 
Diet Time  Pearson Correlation -0.212* 0.089 -0.277** 0.043  
 Sig. (2-tailed) 0.024 0.352 0.005 0.667  
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 N 
 
114 112 103 100  
Age Pearson Correlation 
Sig. (2-tailed) 

































PHQ9 Total Pearson Correlation -0.619** -0.348** -0.651** 0.353**  
 Sig. (2-tailed) 0.000 0.000 0.000 0.000  
 N 
 
114 112 103 100  
BAS-2 Total Pearson Correlation  1 -0.282** 0.682** -0.434**  
 Sig. (2-tailed)  0.003 0.000 0.000  
 N 
 
114 112 103 100  
CDAT Total Pearson Correlation -0.282** 1 -0.251* 0.140  
 Sig. (2-tailed) 0.003  0.011 0.166  
       
 N 112 112 103 100  
CDSES Total Pearson Correlation 0.682** -0.251* 1 -0.358** 
 Sig. (2-tailed) 0.000 0.011  0.000 
 N 103 103 103 100 
EAT-26 Total Pearson Correlation -0.434** 0.140 -0.358* 1 
 Sig. (2-tailed) 0.000 0.166 0.000  
 N 100 100 100 100 
*Indicates significance at p < 0.05 (2-tailed). 
**Indicates significance at p < 0.01 (2-tailed). 
Additionally, time following a gluten-free diet significantly correlated with 
depression scores (r = 0.200, p = 0.033), body appreciation (r = -0.212, p = 0.024), and 
self-efficacy (r = -0.277, p = 0.005). Time following the diet was originally captured as a 
categorical variable and was thus dummy coded prior to analyses. 
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Hypothesis I 
Hypothesis 1 evaluated the magnitude of weight change in relation to depressive 
symptoms, maladaptive eating behaviors, and body image. Prior to analyses, the 
categorical variable of weight change was dummy coded. Specifically, the two highest 
and lowest categories were collapsed into two of the five categories and the middle 
category, “fluctuating”, removed. Thus, magnitude of weight change was quantified 
using a high change group and low change group. The high group included the categories 
“gained weight” and “lost weight”, and the low group included the categories “no 




High Weight Change and Low Weight Change in Women with Celiac Disease (N = 123) 
 
Magnitude of Weight 
Change 
Frequency Percent 
Low Change 37 30.1 
High Change 58 47.2 
 
Regression analyses were then conducted to evaluate the relationship between 
magnitude of weight change and depression after first accounting for current weight and 
time on a gluten-free diet. While the overall model was significant (F =4.519, p = 0.006; 
Table 7), the regression analyses indicated no significant relationship between magnitude 
of weight change and depression (p = 0.843; Table 8). However, current weight and time 
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Table 6 
Overall Regression Analysis of Predictor Variables Current Weight and Diet Time for 
Depression 





Regression 474.784 2 237.392 6.839 0.002 
Residual 2811.501 81 34.710   
Total 3286.286 83    
*Degrees of freedom 
Table 7 
 
Overall Regression Analysis of Predictor Variables Current Weight, Diet Time, and 
Weight Change 
 







     











Total                  3286.286 83    
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Table 8 
 
Coefficients for Predictor Variables of Diet Time, Current Weight, and Weight Change 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 11.603 3.018  3.844 0.000 
Diet Time 2.991 1.351 0.236 2.213 0.030 
Current 
Weight 
0.033 0.013 0.262 2.469 0.016 
Weight 
Change 
-0.273 1.372 -0.021 -0.199 0.843 
 
Regression analyses were then conducted to evaluate the relationship between 
magnitude of weight change and eating behaviors after accounting for current weight and 
time on a gluten-free diet. While the overall model was significant, (F = 4.448, p = 0.015; 
Table 10), the relationship between magnitude of weight change and eating behaviors 
was not statistically significant (p = 0.841; Table 11). Current weight accounted for 
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Table 9 
Overall Regression Analysis for Predictor Variable Current Weight and Eating 
Behaviors 




F Significance  
Regression 0.960 1 0.960 8.973 0.004 
Residual 7.808 73 0.107   
Total 8.768 74    
 *Degrees of freedom 
Table 10  
Overall Regression Analysis for Predictor Variables of Current Weight, Weight Change, 
and Eating Behaviors 




F Significance  
Regression 0.964 2 0.482 4.448 0.015 
Residual 7.804 72 0.108   
Total 8.768 74    
 *Degrees of freedom 
Table 11 
Coefficients for Predictor Variables of Diet Time, Current Weight, and Weight Change 
Model B Standard 
Error 
t  Significance 
(Constant) 0.524 0.173 3.036 0.003 
Current 
Weight 
0.002 0.001 2.923 0.005 
Weight 
Change 
0.016 0.080 0.201 0.841 
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Regression analyses were conducted to evaluate the relationship between 
magnitude of weight change and body image after accounting for current weight and time 
on a gluten-free diet. The relationship between magnitude of weight change and body 
image was not statistically significant (p = 0.769; Table 14). Current weight accounted 
for statistical significance (p < 0.01). 
Table 12 
Overall Analysis for Predictor Variables Diet Time, Current Weight and Body Image 




F Significance  
Regression 19.675 2 9.838 16.486 0.000 
Residual 48.335 81 0.597   
Total 68.010 83    
*Degrees of freedom 
Table 13 
Overall Analysis for Predictor Variables Diet Time, Current Weight, Weight Change, and 
Body Image 





Regression 19.727 3 6.576 16.486 0.000 
Residual 48.283 80 0.604   
Total 68.010 83    
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Table 14 
Coefficients for Predictor Variables of Diet Time, Current Weight, and Weight Change 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 4.763 0.294  16.186 0.000 
Current 
Weight 
-0.008 0.002 -0.468 -4.845 0.000 
Diet Time -0.368 0.177 -0.202 -2.081 0.041 
Weight 
Change 
0.053 0.180 0.028 0.294 0.769 
 
Hypothesis II 
Hypothesis 2 evaluated the relationship between self-efficacy and time on a 
gluten-free diet. Regression analyses were conducted to evaluate the relationship between 
self-efficacy and time on a gluten-free diet after accounting for current weight. Although 
the overall model was found to be significant (F = 4.809, p = 0.010), the relationship 
between self-efficacy and time on a gluten-free diet was not statistically significant (p = 
0.083; Table 17). Current weight did not account for statistical significance (p = .066). 
Table 15 
Overall Regression Analysis with Predictor Variable Current Weight  





Regression 280.924 1 280.924 6.397 0.013 
Residual 4084.065 93 43.915   
Total 4364.989 94    
*Degrees of freedom 
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Table 16 
Overall Regression Analysis with Predictor Variables Current Weight and CDSES Scores  





Regression 413.119 2 206.559 4.809 0.010 
Residual 3951.871 92 42.955   
Total 4364.989 94    
*Degrees of freedom 
Table 17 
Coefficients for Predictor Variable Current Weight and CDSES Scores 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 16.315 2.344  6.959 0.000 
Current 
Weight 
0.026 0.014 0.195 1.858 0.066 
CDSES 
Total 
-0.598 0.341 -0.184 -1.754 0.083 
 
Hypothesis III 
It was hypothesized that women more recently diagnosed with Celiac disease 
(less than one year) would have lower self-efficacy and higher psychosocial dysfunction 
as defined by depression, eating behaviors, and body image, than women who had carried 
a diagnosis for a longer amount of time (one year or more). Regression analyses were 
conducted to evaluate the relationship between time since diagnosis and self-efficacy, 
after accounting for current weight. The relationship between time since diagnosis and 
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self-efficacy was not statistically significant (p = 0.777; Table 20). Current weight 
accounted for statistical significance (p = 0.006).  
Table 18 
Overall Regression Analysis with Predictor Variables Current Weight, Diet Time, and 
Self-Efficacy 





Regression 68.805 2 34.403 9.233 0.000 
Residual 342.814 92 3.726   
Total 411.619 94    
*Degrees of freedom 
Table 19 
Overall Regression Analysis with Predictor Variable Current Weight, Diet Time, 
Diagnosis Time, and Self-Efficacy 





Regression 69.108 3 23.036 6.120 0.001 
Residual 342.512 91 3.764   
Total 411.619 94    
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Table 20 
Coefficients for Predictor Variable Current Weight, Diet Time, and Diagnosis Time  
Model B Standard 
Error 
Beta t  Significance 
(Constant) 8.871 0.694  12.779 0.000 
Current 
Weight 















 Regression analyses were conducted to evaluate the relationship between time 
since diagnosis and depression, after accounting for current weight. The relationship 
between time since diagnosis and depression was not statistically significant (p = 0.890; 
Table 23). Current weight accounted for statistical significance (p = 0.030). 
Table 21  
Overall Regression Analysis for Diet Time, Current Weight, and Depression  





Regression 422.123 2 211.062 5.473 0.006 
Residual 3933.839 102 38.567   
Total 4355.962 104    
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Table 22 
Overall Regression Analysis for Diet Time, Current Weight, Diagnosis Time and 
Depression  





Regression 422.865 3 140.955 3.620 0.016 
Residual 3933.097 101 38.942   
Total 4355.962 104    
 *Degrees of freedom 
Table 23  
Coefficients for Predictor Variables Current Weight, Diet Time, and Diagnosis Time 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 12.350 2.180  5.665 0.000 
Current 
Weight 















Regression analyses were conducted to examine the relationship between time 
since diagnosis and eating behaviors, after accounting for current weight. The 
relationship between time since diagnosis and eating behaviors was not statistically 
significant (p = 0.466; Table 26). Current weight accounted for statistical significance (p 
= 0.012).  
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Table 24 
Overall Regression Analysis for Predictor Variables Diet Time, Current Weight, and 
Eating Behaviors 





Regression 0.794 2 0.397 3.325 0.040 
Residual 10.745 90 0.119   
Total 11.539 92    
 *Degrees of freedom 
Table 25 
Overall Regression Analysis for Diet Time, Current Weight, Diagnosis Time, and Eating 
Behaviors 





Regression 0.858 3 0.286 2.384 0.075 
Residual 10.680 89 120   
Total 11.539 92    
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Table 26  
Coefficients for Predictor Variables Current Weight, Diet Time, and Diagnosis Time 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 0.630 0.124  5.075 0.000 
Current 
Weight 
















Regression analyses were conducted to examine the relationship between time 
since diagnosis and body image, after accounting for current weight. The relationship 
between time since diagnosis and body image was not statistically significant (p = 0.721; 
Table 29). Current weight accounted for statistical significance. 
Table 27 
Overall Regression Analysis for Predictor Variables Diet Time, Current Weight, and 
Body Image 





Regression 16.764 2 8.382 13.193 0.000 
Residual 64.804 102 0.635   
Total 81.569 104    
 *Degrees of freedom 
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Table 28 
Overall Regression Analysis for Predictor Variables Diet Time, Current Weight, 
Diagnosis Time, and Eating Behaviors 





Regression 16.846 3 5.615 8.763 0.000 
Residual 64.722 101 0.641   
Total 81.569 104    
 *Degrees of freedom 
Table 29 
Coefficients for Predictor Variables Current Weight, Diet Time, and Diagnosis Time 
Model B Standard 
Error 
Beta t  Significance 
(Constant) 4.469 0.280  15.979 0.000 
Current 
Weight 
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CHAPTER 5: DISCUSSION 
The purpose of this study was to examine how physical and behavioral factors 
influence psychosocial functioning and adherence to treatment in adult women with 
Celiac disease following the implementation of a gluten-free diet. Self-efficacy, 
depressive symptoms, maladaptive eating behaviors, and body image were examined in 
relation to weight change and gluten-free diet adherence to identify factors that may be 
vital to inform wholistic treatment of adult women with Celiac disease and aid medical 
professionals and mental health clinicians in screening for comorbid conditions and 
increasing treatment adherence. A survey-based method using evidence-based measures 
was used to collect data concerning each variable.  
After accounting for current weight and the time following a gluten-free diet, no 
significant relationship was found between the magnitude of weight change since Celiac 
diagnosis and depression, disordered eating behaviors, or body image. This may be due to 
the categorical method used to split the magnitude of weight change. A continuous 
measure of weight change in pounds may be a more effective approach to try in future 
studies.  
 The average level of depression reported in this study, as measured by the PHQ-9, 
was in the moderately severe clinical range. In another study that used the PHQ-9 to 
measure depression in those with Celiac in a sample of 91 women and 8 men, 
investigators found that 43% of participants met the criteria for depression, compared to 
7% of the general population (Alharbi et al., 2017). While increased depressive 
symptoms were not specifically linked in this study to treatment adherence, weight 
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change, or self-efficacy, further research is needed to better understand the relationship 
between depression and Celiac disease.  
 The average EAT-26 score reported in this study was belo the level of possible 
clinical concern. Approximately 17% of participants in this study reported a score of 20 
or higher. Contrary to the findings of this study, other studies have shown a relationship 
between increased EAT-26 scores and depressive symptoms, as well as increased EAT-
26 scores and reported gastrointestinal symptoms. Sixteen percent of the participant 
group with Celiac disease reported a score of 20 or higher compared to 4% of the healthy 
control group (Passananti et al., 2013).  
 This study found that current weight accounted for the relationship between 
magnitude of weight change since time of diagnosis of Celiac disease and depression, 
disordered eating behaviors, and body image. The relationship between weight and 
depression has been shown to be significant. Research shows that those with higher BMI 
report greater symptoms of depression (Stevens et al., 2018). While this may help to 
explain why current weight influenced depression scale scores in this study, it is unclear 
what mediating factors may also influence the relationship between weight and 
depressive symptoms in general.  
Although this study did not show a relationship between the magnitude of weight 
change and depressive symptoms, another study shows that frequent weight fluctuation 
may be related to increased depressive symptoms. Internalized weight stigma was a 
mediating factor. The direction of weight change did not significantly influence the 
severity of reported depressive symptoms (Quinn et al., 2020). This shows that more 
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research is needed to gain insight into the relationship between weight and depressive 
symptoms with this population to understand their specific needs.  
To better understand the relationship between weight and depression in patients 
with Celiac, one area for future study is internalized weight bias. Internalized weight 
stigma has been shown, in a study examining self-compassion, weight stigma, 
psychological well-being, and eating behaviors, to be related to maladaptive eating 
behaviors (Fekete et al., 2021). Internalized weight stigma was found to be directly 
related to eating behaviors, as opposed to psychological well-being—depression and 
anxiety—being a mediating factor. Participants with greater internalized weight stigma 
reported higher rates of emotional eating and higher rates of restrictive eating.  
Weight stigma is also shown to be positively correlated with body image (Pearl et 
al., 2020). A study examining cognitive behavioral interventions’ effect on internalized 
weight stigma found that participants with greater internalized weight stigma reported 
poorer body image, as measured by the Body Appreciation Scale (Pearl et al., 2020). 
Those who participated in cognitive behavioral therapy to address weight stigma and 
weight loss reported fewer beliefs consistent with weight stigma and increased positive 
body image as compared to a control group.  
Taking into account the impact of weight stigma on body image and eating 
behaviors, cognitive behavioral interventions may have a vital part in treating Celiac 
disease, addressing beliefs associated with weight stigma using cognitive restructuring, 
reducing distress, and replacing unwanted responses to external and internal stigma (Puhl 
et al., 2020). When applied to weight loss interventions, cognitive behavioral approaches 
have also been shown to have success when targeting weight stigma (Pearl et al., 2020). 
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Resulting weight loss in participants in overweight and obese BMI categories challenged 
common beliefs associated by weight stigma, such as laziness and failure to reach goals, 
serving as evidence for alternative responses in cognitive interventions.  
Overall, participants in this study showed poorer adherence to a gluten-free diet 
compared to other studies that used the CDAT (Gladys et al., 2020; Haere et al., 2019). 
While there was no significant relationship between gluten-free diet adherence and the 
variables of depression, self-efficacy, and eating behaviors, it is important to note that 
adherence overall was quite low. Other studies have shown that those with Celiac disease 
have identified external factors as barriers to adherence, such as the cost of gluten-free 
foods, lack of gluten-free foods at restaurants, and pressure to eat at social gatherings 
(Silvester et al., 2016) Most incidents of gluten consumption, whether accidental or 
intentional, occur outside of the home.  
After accounting for current weight and the time following a gluten-free diet, no 
significant relationship was found between self-efficacy and adherence to a gluten-free 
diet. While research is lacking in the relationship between self-efficacy, weight, and 
Celiac disease treatment adherence, there is research to suggest that weight plays a role in 
levels of self-efficacy in other areas (Aime et al., 2017). A study examining BMI and 
academic performance found that overweight and obese female college students reported 
lower academic self-efficacy compared to female college students with BMI in the 
normal range. It has also been shown that greater BMI negatively impacts self-efficacy in 
diabetes treatments that emphasize self-management strategies, such as diet change and 
physical activity (Wichit et al., 2016). This is consistent with the findings of the current 
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study, which identified current weight as a significant predictor of self-efficacy and 
dietary adherence.  
After accounting for current weight, no significant relationship was found 
between length of time since diagnosis and self-efficacy. After accounting for current 
weight, no significant relationship was found between length of time since diagnosis and 
depression, disordered eating behaviors, or body image. While this may contradict 
literature supporting self-efficacy, it is congruent with research that shows that patients 
with Celiac disease hold negative attitudes toward gluten-free diet adherence, even after 
symptom improvement (Whitaker et al., 2009).  
The impacts of COVID-19 on this study are unknown, it is important to note that 
the pandemic could have impacted weight gain and access to gluten-free foods. Studies 
concerning weight change during COVID-19 have shown an increased intake of fast food 
and processed foods as contributing to pandemic weight gains (Bhutani et al., 2021). This 
may also impact not only weight gain for Celiac patients, but also adherence to a gluten-
free diet. Self-quarantine practices are also linked to increased amounts of food eaten 
throughout the day and increased consumption of comfort foods (Zeigler et al., 2020). 
Socioeconomic impacts of COVID-19 may also impact one’s access to gluten-free foods, 
although information on income and socioeconomic status were not collected in this 
study.  
Clinical Implications 
Self-efficacy has been shown to be positively related to treatment adherence for 
diseases such as hypertension, diabetes, and obesity. Patient education programs for such 
diagnoses have shown increased positive patient outcomes (Foroumandi et al., 2011; 
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Steca et al., 2013). While patient education has long been a focus of self-efficacy as 
related to patient outcomes, the results of this study did not find a significant relationship 
between self-efficacy and treatment adherence or other psychosocial variables. While 
research is lacking on the relationship between weight gain and Celiac treatment 
adherence, interventions promoting healthy weight loss or nutrition in addition to a 
gluten-free diet may prove to be more efficacious to women with Celiac disease.  
 Participants in the current study reported notable levels of depression, indicating 
that screenings for depression and evidence-based interventions may be warranted in 
women with Celiac disease. These elevated levels of depression, as well as the low 
reported dietary adherence in our sample, could be explained by Beck’s cognitive triad 
and the role of cognitive errors in depression and behavior (Beck, 1967). According to 
Beck, one’s experience and interpretation of events contributes to cognitive distortions, 
resulting in unwanted mood or behavior (Beck & Rush, 1979). How patients interpret or 
experience their symptomology may be a significant factor in reported depressive 
symptoms or adherence. The physical symptomology of Celiac disease varies widely 
among individuals; however, participants in this study were not asked to report 
experiences of symptoms. The CDAT uses two items assessing for headaches and energy 
level to measure adherence, however, this does not take into account gastrointestinal 
symptoms, symptoms caused by refractory Celiac disease, or asymptomatic Celiac 
disease.  
Cognitive interpretations of symptomology, or experiences adjusting to gluten-
free diet adherence, may directly impact mood and behavior. Physical symptoms in 
response to accidental or intentional gluten exposure may be interpreted as failure or 
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punishment, which may reinforce depressed mood and poor dietary adherence rather than 
motivate behavior change and instill hopefulness. The role of external stressors in 
relation to quality of life reported by Celiac patients shows that such experiences are 
significant to how diagnoses and ability to adhere to treatment is perceived (Arigo et al., 
2012)  Experiences in social settings, perceived support from peers and family, perceived 
knowledge about the disease, and access to gluten-free foods could be further examined 
qualitatively to identify the role of cognitive distortions and mood in relation to treatment 
adherence and reported depressive symptoms.  
Additionally, it may be beneficial to further explore the role of cognitive 
behavioral interventions in relation to quality of life and treatment adherence in patients 
with Celiac disease. There are several areas of importance that could be expanded upon: 
the potential role of anxiety or other conditions that were not screened for, coping 
mechanisms that may influence treatment adherence, and the relationship between the 
cognitive behavioral model and health outcomes.  
Although maladaptive eating behaviors and depression were examined in this 
study, both were not found to be significant in relation to treatment adherence. There may 
be other conditions, such as anxiety, that could be screened for in future research. Since 
weight proved to be a significant factor in most hypotheses, Celiac patients with a higher 
BMI or recent weight gain should be screened for depression, maladaptive eating 
behaviors, and deviation from treatment adherence.  
Cognitive behavioral interventions may have a positive effect on both depression 
and treatment adherence. Since depression, eating behaviors, and body image did not 
relate significantly to diet adherence, examining coping strategies used may help to 
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inform treatment interventions. Research shows that Celiac patients who engage in 
emotion-focused coping strategies such as venting, self-blame, and denial reported lower 
quality of life than those who engaged in coping strategies such as positive reframing, 
acceptance, and planning (Smith & Goodfellow, 2011). Expanding on this research by 
testing outcomes with structured cognitive behavioral approaches is warranted.  
Strengths 
  There are several strengths of note in this study. Adequate sample size was 
achieved to conduct statistical analyses for each hypothesis. All measures used were 
validated and empirically supported to measure each variable. The population of interest 
in this study has been understudied. This study emphasizes the need for further research 
concerning not only Celiac disease, but also the specific experiences of adult women with 
this diagnosis.  
Limitations 
There are several limitations to this study that must be considered. Participants 
were asked to report their own BMI, both pre-diagnosis and at time of participation. The 
accuracy of this reported information is completely reliant on participants’ self-reports. 
Research has shown that women are often inaccurate in their self-report of height and 
weight (Meyer et al., 2009). Height tends to be overestimated. Women with concerns 
about eating habits tend to overestimate their weight, while women with body image 
concerns tend to underestimate their weight. Additionally, clinical information to confirm 
a diagnosis of Celiac disease was not collected. Additionally, response to a gluten-free 
diet varies regardless of strict adherence. Refractory Celiac disease results in chronic 
gastrointestinal symptoms, even with strict gluten-free diet adherence. All data were self-
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reported, which is subject to bias. This study was conducted using a cross-sectional 
design, so the experiences of participants over time cannot be predicted and there was no 
control group for comparison. Participants were recruited online, and diagnosis of Celiac 
disease was self-reported. 
Future directions 
 In conclusion, further research is needed to better understand how to meet the 
needs of patients with Celiac disease, particularly in regards to depression and adherence 
to a gluten-free diet. Better understanding of the relationship between current weight, 
self-efficacy, and treatment adherence would be beneficial. Research examining how 
adult women diagnosed with Celiac disease think and feel about their current weight 
might also provide direction to identify what other variables or relationships should be 
examined. Though it is unclear which screening or treatment methods would be most 
effective, it is clear that the comorbidities that many women with Celiac disease 
experience need to be addressed. Perhaps with qualitative research examining the 
subjective experiences of individuals with Celiac disease, the nature of the relationship 
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